Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Levels of Health Promotion and Illness Prevention

Levels of Health Promotion and Illness Prevention

Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Using user-centered design to better understand challenges faced during genetic analyses by novice genomic researchers.

Frontiers in bioinformatics·2026

Same author

Estimation of population-specific values of theta for PowerPlex Y23 profiles.

Forensic science international. Genetics·2024

Same author

Author Correction: Genetic variation in the human leukocyte antigen region confers susceptibility to Clostridioides difficile infection.

Scientific reports·2023

Same author

Genetic variation in the human leukocyte antigen region confers susceptibility to Clostridioides difficile infection.

Scientific reports·2023

Same author

Translating the Diabetes Prevention Program Lifestyle Intervention to the Military Setting.

Military medicine·2022

Same author

Unmanaged Pharmacogenomic and Drug Interaction Risk Associations with Hospital Length of Stay among Medicare Advantage Members with COVID-19: A Retrospective Cohort Study.

Journal of personalized medicine·2021

Same journal

A Secular Increase in the Incidence of Islet Autoimmunity Among Colorado Children With Moderate-Risk HLA Genotypes.

Diabetes care·2026

Same journal

Clinical and Biochemical Recovery From Immune Checkpoint Inhibitor-Induced Diabetes With Seroconversion of GAD Antibodies.

Diabetes care·2026

Same journal

State Insulin Out-of-Pocket Cap Policies and Estimated Eligible Populations in the United States, 2019-2026.

Diabetes care·2026

Same journal

Genetic Determinants of Macronutrient Intake Are Associated With Specific Food Intake in Youth: A Cohort Study Across Childhood and Adolescence.

Diabetes care·2026

Same journal

A Novel Electronic Medical Record Search Method to Identify Patients With Ketosis-Prone Diabetes: Implications for Discovery of Atypical Diabetes.

Diabetes care·2026

Same journal

Real-Time Continuous Glucose Monitoring Among People With Type 2 Diabetes and End-Stage Kidney Failure Undergoing Maintenance Hemodialysis: A Randomized Clinical Trial.

Diabetes care·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 9, 2026

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Implementing a state-based cardiovascular disease and diabetes prevention program.

Karl K Vanderwood¹, Taryn O Hall, Todd S Harwell

¹Montana Department of Public Health and Human Services, Helena, Montana, USA. kvanderwood@mt.gov

|September 1, 2010

Summary

This summary is machine-generated.

This study shows that an adapted Diabetes Prevention Program effectively helps adults lose weight and reduce cardiovascular disease (CVD) and diabetes risk factors. The intervention demonstrated feasibility in a state-coordinated setting.

More Related Videos

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

Related Experiment Videos

Last Updated: Jun 9, 2026

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

Area of Science:

Public Health
Preventive Medicine
Cardiology

Background:

Adults at high risk for cardiovascular disease (CVD) and diabetes require effective lifestyle interventions.
The Diabetes Prevention Program (DPP) is a proven model for weight loss and risk reduction.

Purpose of the Study:

To assess the effectiveness of an adapted DPP intervention in reducing weight and cardiometabolic risk factors.
To evaluate the feasibility of implementing such a program in a state-coordinated healthcare system.

Main Methods:

A group-based lifestyle intervention was implemented across eight healthcare facilities starting in 2008.
Participants completed 16 core weekly sessions followed by 6 monthly maintenance sessions.

Main Results:

Out of 1,003 enrolled participants, 816 (81%) completed the core sessions and 578 (58%) completed maintenance.
45% and 49% of participants achieved the 7% weight loss goal after core and maintenance phases, respectively.
Significant improvements were observed in blood pressure, fasting glucose, and LDL cholesterol levels.

Conclusions:

State-coordinated CVD and diabetes prevention programs, utilizing adapted DPP interventions, are feasible.
These programs can successfully achieve significant weight loss and improve key cardiometabolic risk markers.